Abstract: Provided herein are methods and computer-readable storage media related to cell-free DNA and uses thereof to determine risk of a condition, such as transplant rejection or cancer, in a subject.
Abstract: An esophageal device is used to recognize, diagnose, characterize, or relieve an impact of an abnormal or defective UES anatomy, physiology, or functionality. In one implementation, the esophageal device measures a UES response to esophageal fluid infusion to detect or characterize an abnormality or defective UES anatomy, physiology, or functionality. An Upper Esophageal Sphincter compression device is used to increase intra-luminal pressure within the Upper Esophageal Sphincter of a patient in order relieve an impact of an abnormal or defective UES anatomy, physiology, or functionality.
Abstract: In some embodiments, an apparatus includes a data management module implemented in at least one of a memory or a processor. The data management module is configured to associate a different classification parameter with each data set from a set of data sets stored in the memory. The data management module is configured to store, in a first data set and using a first storage scheme based on a type of the classification parameter of the first data set, a set of values. Each value is associated with a different object. The data management module is configured to store, in a second data set and using a second storage scheme different from the first storage scheme and based on a type of the classification parameter of the second data set, a set of values. Each value is associated with a different object.
Type:
Application
Filed:
June 15, 2015
Publication date:
December 15, 2016
Applicant:
THE MEDICAL COLLEGE OF WISCONSIN, INC.
Inventors:
Arthur Michael WEBORG, JR., Brandon Michael WILK, Elizabeth Anabel WORTHEY
Abstract: The present invention provides a method for preferentially reducing the proliferation of cystic epithelial cells in the kidney or bile duct in a mammal in need thereof by administering a 20-HETE synthesizing enzyme inhibitor or a 20-HETE antagonist to the mammal in an amount sufficient to preferentially reduce the proliferation of cystic epithelial cells over normal epithelial cells such as tubule epithelial cells in the kidney or bile duct. The present invention also provides a method for preventing or treating autosomal dominant polycystic kidney disease (ADPKD), autosomal recessive polycystic kidney disease (ARPKD), ARPKD associated congenital hepatic fibrosis, ARPKD associated Caroli's disease, or cholangiocarcinoma in a mammal in need thereof by administering a 20-HETE synthesizing enzyme inhibitor or a 20-HETE antagonist to the mammal in an amount sufficient to prevent or treat the disease.
Type:
Grant
Filed:
June 12, 2014
Date of Patent:
December 6, 2016
Assignee:
The Medical College of Wisconsin, Inc.
Inventors:
William E. Sweeney, Ellis D. Avner, Richard J. Roman
Abstract: An optical coherence tomography system that includes an optical device having an adjustable optical element configured to displace a pupil entry point of light is provided. Optical coherence tomography methods using the optical coherence tomography system are also provided. The subject optical coherence tomography systems and methods find use in a variety of different applications, including imaging applications.
Type:
Grant
Filed:
February 15, 2013
Date of Patent:
August 30, 2016
Assignees:
The Regents of the University of California, The Medical College of Wisconsin, Inc.
Inventors:
Brandon Lujan, Austin Roorda, Joseph Carroll, Carlos Rivera-Carpio, Vikram Makhijani
Abstract: Compounds and compositions comprising epoxyeicosatrienoic acid (EET) analogs that act as EET agonists and are useful as medications in the treatment of drug-induced nephrotoxicity, hypertension and other related conditions. Methods of making and using the compounds and compositions are further described.
Type:
Grant
Filed:
July 30, 2015
Date of Patent:
August 23, 2016
Assignees:
The Medical College of Wisconsin, Inc., The Board of Regents of the University of Texas System
Inventors:
John David Imig, William B. Campbell, John Russell Falck
Abstract: A method for reconstructing a plurality of images depicting a subject from image data that is simultaneously acquired from a corresponding plurality of slice locations with a magnetic resonance imaging (MRI] system is provided. Image data is acquired following the application of radio frequency (RF] energy to the plurality of slice locations. The RF energy is tailored to provide a different phase to each of the plurality of slice locations. Reference image data is also acquired for each slice location following the application of RF energy that has the same phase as is used to excite the respective slice location for the acquisition of the image data. Aliased images are reconstructed from the image data, and reference images are reconstructed from the reference image data. Using both of these image sets, an unaliased image is produced for each of the plurality of slice locations.
Type:
Grant
Filed:
February 25, 2011
Date of Patent:
August 16, 2016
Assignee:
The Medical College of Wisconsin, Inc.
Inventors:
Andrzej Jesmanowicz, Shi-Jiang Li, James S. Hyde
Abstract: The present invention provides a novel CXCL12-?2 locked dimer polypeptide, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of cancer, inflammatory disorders, autoimmune disease, and HIV/AIDS.
Type:
Grant
Filed:
July 8, 2013
Date of Patent:
May 24, 2016
Assignees:
The Medical College of Wisconsin, The Rockefeller University
Inventors:
Brian F. Volkman, Christopher T. Veldkamp, Francis C. Peterson, Thomas Sakmar, Christoph H. Seibert
Abstract: Provided herein are compositions for reducing CLPTM1L expression in a cell as well as methods for using such compositions to treat or prevent cancer in a subject. In particular, compositions comprising RNAi-inducing constructs targeted to CLPTM1L and methods of administering such compositions to a subject to treat or prevent a disease or condition associated with CLPTM1L over-expression (e.g., lung cancer) are provided herein.
Type:
Grant
Filed:
March 7, 2014
Date of Patent:
February 23, 2016
Assignee:
The Medical College of Wisconsin, Inc.
Inventors:
Michael Anthony James, Haris G. Vikis, Ming You
Abstract: The present invention provides reagents and methods for modulating cone photoreceptor activity, and devices for assessment of cone photoreceptor activity.
Type:
Grant
Filed:
November 8, 2013
Date of Patent:
December 1, 2015
Assignees:
University of Washington Through its Center for Commercialization, University of Florida Research Foundation, Incorporated, Medical College of Wisconsin
Inventors:
Jay Neitz, Maureen Neitz, James A. Kuchenbecker, William W. Hauswirth
Abstract: This invention relates to a system that adaptively compensates for subject motion in real-time in an imaging system. An object orientation marker (30), preferably a retro-grate reflector (RGR), is placed on the head or other body organ of interest of a patient (P) during a scan, such as an MRI scan. The marker (30) makes it possible to measure the six degrees of freedom (x, y, and z-translations, and pitch, yaw, and roll), or “pose”, required to track motion of the organ of interest. A detector, preferably a camera (40), observes the marker (30) and continuously extracts its pose. The pose from the camera (40) is sent to the scanner (120) via an RGR processing computer (50) and a scanner control and processing computer (100), allowing for continuous correction of scan planes and position (in real-time) for motion of the patient (P).
Type:
Grant
Filed:
April 28, 2015
Date of Patent:
September 22, 2015
Assignees:
The Queen's Medical Center, The University of Hawaii, The Medical College of Wisconsin, Inc., UWM Research Foundation, Inc.
Inventors:
Thomas Michael Ernst, Thomas Edmund Prieto, Brian Stewart Randall Armstrong
Abstract: Compounds and compositions comprising epoxyeicosatrienoic acid (EET) analogs that act as EET agonists and are useful as medications in the treatment of drug-induced nephrotoxicity, hypertension and other related conditions. Methods of making and using the compounds and compositions are further described.
Type:
Grant
Filed:
April 4, 2012
Date of Patent:
September 8, 2015
Assignees:
The Medical College of Wisconsin, Inc., The Board of Regents of the University of Texas System
Inventors:
John David Imig, William B. Campbell, John Russell Falck
Abstract: This invention relates to a system that adaptively compensates for subject motion in real-time in an imaging system. An object orientation marker (30), preferably a retro-grate reflector (RGR), is placed on the head or other body organ of interest of a patient (P) during a scan, such as an MRI scan. The marker (30) makes it possible to measure the six degrees of freedom (x, y, and z-translations, and pitch, yaw, and roll), or “pose”, required to track motion of the organ of interest. A detector, preferably a camera (40), observes the marker (30) and continuously extracts its pose. The pose from the camera (40) is sent to the scanner (120) via an RGR processing computer (50) and a scanner control and processing computer (100), allowing for continuous correction of scan planes and position (in real-time) for motion of the patient (P).
Type:
Grant
Filed:
September 23, 2013
Date of Patent:
July 7, 2015
Assignees:
The Queen's Medical Center, The University of Hawaii, The Medical College of Wisconsin, Inc., UWM Research Foundation, Inc.
Inventors:
Thomas Michael Ernst, Thomas Edmund Prieto, Brian Stewart Randall Armstrong
Abstract: Provided herein are methods and computer-readable storage media related to cell-free DNA and uses thereof to determine risk of a condition, such as transplant rejection or cancer, in a subject.
Abstract: Apocynin derivative compounds, active pharmaceutical ingredients, dosage forms, and methods of use thereof as neuroprotectants in the brain of mammals.
Type:
Grant
Filed:
April 15, 2010
Date of Patent:
February 24, 2015
Assignee:
The Medical College of Wisconsin, Inc.
Inventors:
Balaraman Kalyanaraman, Joy Joseph, Anumantha Kanthasamy
Abstract: The present invention provides peptide-based peroxidase inhibitors having the formula AA1-AA2-AA3, wherein AA1 is a positively charged, negatively charged or neutral amino acid, AA2 is a redox active amino acid, and AA3 is an amino acid possessing a reducing potential such that AA3 is capable of undergoing a redox reaction with a radical of amino acid AA2 or a retro or retro-inverso analog thereof. The result of such a combination is a highly effective inhibitor of peroxidase activity that has potent anti-inflammatory properties in widely diverse models of vascular disease and injury. Exemplary tripeptides effectively inhibit peroxidase mediated LDL oxidation, increase vasodilation in SCD mice, inhibit eosinophil infiltration and collagen deposition in asthma mice, inhibit acute lung injury, and decrease ischemic injury of the heart.
Type:
Grant
Filed:
November 15, 2013
Date of Patent:
January 20, 2015
Assignee:
The Medical College of Wisconsin, Inc.
Inventors:
Hao Zhang, Yang Shi, Hao Xu, Kirkwood A. Pritchard, Jr.
Abstract: Methods and kits for measuring levels of von Willebrand factor function in a sample without using a platelet aggregation agonist, such as ristocetin, comprising recombinant glycoprotein Ib? having at least two of a G233V, D235Y and M239V mutations and an agent to detect a complex between the recombinant glycoprotein Ib? and von Willebrand factor.
Type:
Grant
Filed:
November 6, 2012
Date of Patent:
October 21, 2014
Assignees:
Blood Center Research Foundation, The Medical College of Wisconsin, Inc.
Abstract: The present invention provides a method for preferentially reducing the proliferation of cystic epithelial cells in the kidney or bile duct in a mammal in need thereof by administering a 20-HETE synthesizing enzyme inhibitor or a 20-HETE antagonist to the mammal in an amount sufficient to preferentially reduce the proliferation of cystic epithelial cells over normal epithelial cells such as tubule epithelial cells in the kidney or bile duct. The present invention also provides a method for preventing or treating autosomal dominant polycystic kidney disease (ADPKD), autosomal recessive polycystic kidney disease (ARPKD), ARPKD associated congenital hepatic fibrosis, ARPKD associated Caroli's disease, or cholangiocarcinoma in a mammal in need thereof by administering a 20-HETE synthesizing enzyme inhibitor or a 20-HETE antagonist to the mammal in an amount sufficient to prevent or treat the disease.
Type:
Grant
Filed:
September 13, 2007
Date of Patent:
September 30, 2014
Assignee:
The Medical College of Wisconsin, Inc.
Inventors:
William E. Sweeney, Ellis D. Avner, Richard J. Roman